FDA Import Refusal E4W-0037172-5/10002/12 — Akron Pharma, Inc.
The FDA refused shipment E4W-0037172-5/10002/12 from Akron Pharma, Inc. (United States) on January 15, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charges: 118,3280,472,473,75
Refusal Details
- Date
- January 15, 2026
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 60LBA01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 118,3280,472,473,75